Meridian Bioscience Inc. (VIVO:NASDAQ) Investor Relations Material

Overview

Meridian is a leading life science company that specializes in developing and distributing a range of innovative diagnostic test kits, rare reagents, and specialty biologicals. The company's products allow for accurate, simple, and speedy diagnosis and treatment of various medical conditions, including infections and lead poisoning. Meridian's diagnostic products are highly efficient, requiring little or no special equipment, and are designed to enhance patient well-being while simultaneously reducing healthcare costs. The company has a strong presence in the gastrointestinal, upper respiratory infections, and blood lead level testing markets.

Frequently Asked Questions

What is Meridian Bioscience Inc.'s ticker?

Meridian Bioscience Inc.'s ticker is VIVO

What exchange is Meridian Bioscience Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Meridian Bioscience Inc.'s headquarters?

They are based in Cincinnati, Ohio

How many employees does Meridian Bioscience Inc. have?

There are 201-500 employees working at Meridian Bioscience Inc.

What is Meridian Bioscience Inc.'s website?

It is http://www.meridianbioscience.com

What type of sector is Meridian Bioscience Inc.?

Meridian Bioscience Inc. is in the Healthcare sector

What type of industry is Meridian Bioscience Inc.?

Meridian Bioscience Inc. is in the Diagnostic Substances industry

Who are Meridian Bioscience Inc.'s peers and competitors?

The following five companies are Meridian Bioscience Inc.'s industry peers:

- Co-Diagnostics Inc

- Castle Biosciences

- Bionano Genomics

- Integral Diagnostics

- Danaher